MET and cancer: In contrast, Simm530 treatment exerted little anti-proliferative effect in cells with low c-Met expression or activation (cytotoxicity IC50 values of >50 μM) (Figure 3A), exhibiting at least a 50,000-fold less potency than that of c-Met-addicted cancer cells.